Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9781603, 11 pages
https://doi.org/10.1155/2017/9781603
Research Article

Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases

1Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Professor Lineu Prestes Av 580, Cidade Universitária, 05508-000 São Paulo, SP, Brazil
2Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 8613 114th St NW, Edmonton, AB, Canada T6G 2H7
3Seroepidemiology, Cellular and Molecular Immunology Laboratory, Institute of Tropical Medicine, University of São Paulo, Dr. Enéas de Carvalho Aguiar 470, Jardim América, 05403-000 São Paulo, SP, Brazil

Correspondence should be addressed to Nádia Bou-Chacra; rb.psu@arcahc

Received 8 September 2016; Accepted 5 January 2017; Published 1 February 2017

Academic Editor: Sanjula Baboota

Copyright © 2017 Lis Marie Monteiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. L. Lindoso, J. M. Costa, I. T. Queiroz, and H. Goto, “Review of the current treatments for leishmaniases,” Research and Reports in Tropical Medicine, vol. 3, pp. 69–77, 2012. View at Publisher · View at Google Scholar
  2. J. Alvar, S. L. Croft, P. Kaye, A. Khamesipour, S. Sundar, and S. G. Reed, “Case study for a vaccine against leishmaniasis,” Vaccine, vol. 31, no. 2, pp. B244–B249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Kobets, I. Grekov, and M. Lipoldová, “Leishmaniasis: prevention, parasite detection and treatment,” Current Medicinal Chemistry, vol. 19, no. 10, pp. 1443–1474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. T. S. Tiuman, A. O. Santos, T. Ueda-Nakamura, B. P. D. Filho, and C. V. Nakamura, “Recent advances in leishmaniasis treatment,” International Journal of Infectious Diseases, vol. 15, no. 8, pp. e525–e532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. K. Singh, A. Srivastava, J. K. Gour, and V. K. Tiwari, “Targeting Leishmania species: nanotechnological prospects,” Advanced Science Letters, vol. 5, no. 1, pp. 11–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Van De Ven, M. Vermeersch, R. E. Vandenbroucke et al., “Intracellular drug delivery in Leishmania-infected macrophages: evaluation of saponin-loaded PLGA nanoparticles,” Journal of Drug Targeting, vol. 20, no. 2, pp. 142–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Das, W. K. Ng, and R. B. H. Tan, “Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?” European Journal of Pharmaceutical Sciences, vol. 47, no. 1, pp. 139–151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Chime, F. C. Kenechukwu, and A. A. Attama, “Nanoemulsions—advances in formulation, characterization and applications in drug delivery,” in Application of Nanotechnology in Drug Delivery, A. D. Sezer, Ed., chapter 3, InTech, Rijeka, Croatia, 2014. View at Publisher · View at Google Scholar
  9. S. Weber, A. Zimmer, and J. Pardeike, “Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 86, no. 1, pp. 7–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. C. Chen, J.-W. Huang, and J. Pang, “An investigation of optimum NLC-sunscreen formulation using taguchi analysis,” Journal of Nanomaterials, vol. 2013, Article ID 463732, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Cirri, M. Bragagni, N. Mennini, and P. Mura, “Development of a new delivery system consisting in ‘drug - in cyclodextrin - in nanostructured lipid carriers’ for ketoprofen topical delivery,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 80, no. 1, pp. 46–53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. N. M. Ribeiro, M. Franz-Montan, M. C. Breitkreitz et al., “Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry,” European Journal of Pharmaceutical Sciences, vol. 93, pp. 192–202, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kovács, S. Berkó, E. Csányi, and I. Csóka, “Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method,” European Journal of Pharmaceutical Sciences, vol. 99, pp. 246–257, 2017. View at Publisher · View at Google Scholar
  14. International Council for Harmonisation, “Guidance for Industry, Q8(R2) Pharmaceutical Development,” rev. 2, 2009.
  15. K. W. Kasongo, J. Pardeike, R. H. Müller, and R. B. Walker, “Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers,” Journal of Pharmaceutical Sciences, vol. 100, no. 12, pp. 5185–5196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. E. B. Souto and R. H. Müller, “SLN and NLC for topical delivery of ketoconazole,” Journal of Microencapsulation, vol. 22, no. 5, pp. 501–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Freitas and R. H. Müller, “Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 47, no. 2, pp. 125–132, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. V. B. Junyaprasert, V. Teeranachaideekul, E. B. Souto, P. Boonme, and R. H. Müller, “Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation,” International Journal of Pharmaceutics, vol. 377, no. 1-2, pp. 207–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Severino, M. H. A. Santana, and E. B. Souto, “Optimizing SLN and NLC by 22 full factorial design: effect of homogenization technique,” Materials Science and Engineering: C, vol. 32, no. 6, pp. 1375–1379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Muchow, P. Maincent, R. H. Müller, and C. M. Keck, “Testosterone undecanoate—increase of oral bioavailability by nanostructured lipid carriers (NLC),” journal of Pharmaceutical Technology and Drug Research, vol. 2, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  21. G. Derringer and R. Suich, “Simultaneous optimization of several response variables,” Journal of Quality Technology, vol. 12, no. 4, pp. 214–219, 1980. View at Google Scholar
  22. U. Natarajan, P. R. Periyanan, and S. H. Yang, “Multiple-response optimization for micro-endmilling process using response surface methodology,” The International Journal of Advanced Manufacturing Technology, vol. 56, no. 1, pp. 177–185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Venkatesh, M. I. A. Majid, S. M. Mansor, N. K. Nair, S. L. Croft, and V. Navaratnam, “In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone,” Drug Development and Industrial Pharmacy, vol. 36, no. 6, pp. 735–743, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. R. H. Müller, S. Runge, V. Ravelli, W. Mehnert, A. F. Thünemann, and E. B. Souto, “Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals,” International Journal of Pharmaceutics, vol. 317, no. 1, pp. 82–89, 2006. View at Publisher · View at Google Scholar
  25. S. Nikolić, C. M. Keck, C. Anselmi, and R. H. Müller, “Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters,” International Journal of Pharmaceutics, vol. 414, no. 1-2, pp. 276–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. I. Mendes, A. C. Silva, J. A. M. Catita, F. Cerqueira, C. Gabriel, and C. M. Lopes, “Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity,” Colloids and Surfaces B: Biointerfaces, vol. 111, pp. 755–763, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. T. B. Devkar, A. R. Tekade, and K. R. Khandelwal, “Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer,” Colloids and Surfaces B: Biointerfaces, vol. 122, pp. 143–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Patil-Gadhe and V. Pokharkar, “Montelukast-loaded nanostructured lipid carriers: Part I oral bioavailability improvement,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 88, no. 1, pp. 160–168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Pardeike, S. Weber, T. Haber et al., “Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application,” International Journal of Pharmaceutics, vol. 419, no. 1-2, pp. 329–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Severino, S. C. Pinho, E. B. Souto, and M. H. A. Santana, “Polymorphism, crystallinity and hydrophilic–lipophilic balance of stearic acid and stearic acid–capric/caprylic triglyceride matrices for production of stable nanoparticles,” Colloids and Surfaces B: Biointerfaces, vol. 86, no. 1, pp. 125–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Liu, C. I. Okeke, L. Zhang et al., “Mixed polyethylene glycol-modified breviscapine-loaded solid lipid nanoparticles for improved brain bioavailability: preparation, characterization, and in vivo cerebral microdialysis evaluation in adult Sprague dawley rats,” AAPS PharmSciTech, vol. 15, no. 2, pp. 483–496, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. E. S. Averina, R. H. Müller, D. V. Popov, and L. D. Radnaeva, “Physical and chemical stability of nanostructured lipid drug carriers (NLC) based on natural lipids from Baikal region (Siberia, Russia),” Pharmazie, vol. 66, no. 5, pp. 348–356, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Wang, Y. Liu, S. Wei, and Z. Yan, “Application of response surface methodology to optimise supercritical carbon dioxide extraction of essential oil from Cyperus rotundus Linn.,” Food Chemistry, vol. 132, no. 1, pp. 582–587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. T. K. Trinh and L. S. Kang, “Response surface methodological approach to optimize the coagulation–flocculation process in drinking water treatment,” Chemical Engineering Research and Design, vol. 89, no. 7, pp. 1126–1135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Lin, Y. Pan, Y. Shi, X. Huang, N. Jia, and J.-Y. Jiang, “Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain,” Nanotechnology, vol. 23, no. 16, Article ID 165101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Fang, B. Shi, Y.-Y. Pei, M.-H. Hong, J. Wu, and H.-Z. Chen, “In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size,” European Journal of Pharmaceutical Sciences, vol. 27, no. 1, pp. 27–36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. D. C. Montgomery, Design and Analysis of Experiments, John Wiley & Sons, Hoboken, NJ, USA, 6th edition, 2004. View at MathSciNet
  38. H. Kunieda, K. Ozawa, K. Aramaki, A. Nakano, and C. Solans, “Formation of microemulsions in mixed ionic-nonionic surfactant systems,” Langmuir, vol. 14, no. 2, pp. 260–263, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. J. G. Moloughney and N. Weisleder, “Poloxamer 188 (P188) as a membrane resealing reagent in biomedical applications,” Recent Patents on Biotechnology, vol. 6, no. 3, pp. 200–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Hao, X. Wang, Y. Bi et al., “Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery,” Colloids and Surfaces B: Biointerfaces, vol. 114, pp. 111–120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Chinsriwongkul, P. Chareanputtakhun, T. Ngawhirunpat et al., “Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug,” AAPS PharmSciTech, vol. 13, no. 1, pp. 150–158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Yuan, L.-L. Wang, Y.-Z. Du, J. You, F.-Q. Hu, and S. Zeng, “Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification,” Colloids and Surfaces B: Biointerfaces, vol. 60, no. 2, pp. 174–179, 2007. View at Publisher · View at Google Scholar · View at Scopus